Cited In for PMID: 9484812

Year	Number of Results
1998	1
1999	2
2000	2
2001	2
2003	2
2005	1
2006	3
2007	5
2009	1
2010	3
2011	4
2012	2
2013	6
2014	2
2015	4
2016	4
2017	4
2018	4
2019	2
2020	1
2021	2
2022	2
2023	1
2024	0

1

Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.

Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW, Hudes GR. Ranganathan S, et al. Br J Cancer. 1998 Feb;77(4):562-6. doi: 10.1038/bjc.1998.91. Br J Cancer. 1998. PMID: 9484812 Free PMC article.

2

2-Methoxyestradiol as an Antiproliferative Agent for Long-Term Estrogen-Deprived Breast Cancer Cells.

Hirao-Suzuki M, Kanameda K, Takiguchi M, Sugihara N, Takeda S. Hirao-Suzuki M, et al. Curr Issues Mol Biol. 2023 Sep 9;45(9):7336-7351. doi: 10.3390/cimb45090464. Curr Issues Mol Biol. 2023. PMID: 37754248 Free PMC article.

3

Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.

Chen G, Yan J. Chen G, et al. Curr Protein Pept Sci. 2022;23(11):791-809. doi: 10.2174/1389201023666220928120902. Curr Protein Pept Sci. 2022. PMID: 36173063 Free PMC article.

4

βIII-Tubulin Gene Regulation in Health and Disease.

Duly AMP, Kao FCL, Teo WS, Kavallaris M. Duly AMP, et al. Front Cell Dev Biol. 2022 Apr 28;10:851542. doi: 10.3389/fcell.2022.851542. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35573698 Free PMC article. Review.

5

Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy.

Nawara HM, Afify SM, Hassan G, Zahra MH, Seno A, Seno M. Nawara HM, et al. Biomedicines. 2021 May 2;9(5):500. doi: 10.3390/biomedicines9050500. Biomedicines. 2021. PMID: 34063205 Free PMC article. Review.

6

Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells.

Fang CT, Kuo HH, Yuan CJ, Yao JS, Yih LH. Fang CT, et al. Cell Death Discov. 2021 May 20;7(1):118. doi: 10.1038/s41420-021-00495-z. Cell Death Discov. 2021. PMID: 34016960 Free PMC article.

7

Back to the Future: Rethinking the Great Potential of lncRNA_S for Optimizing Chemotherapeutic Response in Ovarian Cancer.

Elsayed AM, Amero P, Salama SA, Abdelaziz AH, Lopez-Berestein G, Rodriguez-Aguayo C. Elsayed AM, et al. Cancers (Basel). 2020 Aug 25;12(9):2406. doi: 10.3390/cancers12092406. Cancers (Basel). 2020. PMID: 32854207 Free PMC article. Review.

8

Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.

Arnst KE, Wang Y, Lei ZN, Hwang DJ, Kumar G, Ma D, Parke DN, Chen Q, Yang J, White SW, Seagroves TN, Chen ZS, Miller DD, Li W. Arnst KE, et al. Mol Pharmacol. 2019 Jul;96(1):73-89. doi: 10.1124/mol.118.114801. Epub 2019 May 1. Mol Pharmacol. 2019. PMID: 31043459 Free PMC article.

9

Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer.

Kashyap VK, Wang Q, Setua S, Nagesh PKB, Chauhan N, Kumari S, Chowdhury P, Miller DD, Yallapu MM, Li W, Jaggi M, Hafeez BB, Chauhan SC. Kashyap VK, et al. J Exp Clin Cancer Res. 2019 Jan 23;38(1):29. doi: 10.1186/s13046-018-1009-7. J Exp Clin Cancer Res. 2019. PMID: 30674344 Free PMC article.

10

High expression of class III β-tubulin in upper gastrointestinal cancer types.

Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin NC, Simon R, Lang DS, Neubauer E, Göbel C, Heinrich MC, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, Lühr C, Noack M, Reiswich V, Weidemann S, Bockhorn M, Perez D, Izbicki JR, Sauter G, Jacobsen F. Höflmayer D, et al. Oncol Lett. 2018 Dec;16(6):7139-7145. doi: 10.3892/ol.2018.9502. Epub 2018 Sep 25. Oncol Lett. 2018. PMID: 30546449 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

57 results

Results by year